Invesco
NTUS

Invesco’s Natus Medical Inc NTUS Stock Holding History

Invesco’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-202,625
Closed -$6.64M – 4104
2022
Q2 		$6.64M Sell
202,625
-2,772
-1% -$87.6K ﹤0.01% 2126
2022
Q1 		$5.4M Sell
205,397
-9,501
-4% -$232K ﹤0.01% 2334
2021
Q4 		$5.1M Sell
214,898
-3,157
-1% -$77.9K ﹤0.01% 2394
2021
Q3 		$5.47M Sell
218,055
-14,509
-6% -$370K ﹤0.01% 2339
2021
Q2 		$6.04M Sell
232,564
-392,489
-63% -$10.7M ﹤0.01% 2348
2021
Q1 		$16M Sell
625,053
-108,903
-15% -$2.79M ﹤0.01% 1683
2020
Q4 		$14.7M Sell
733,956
-141,545
-16% -$2.77M ﹤0.01% 1597
2020
Q3 		$15M Buy
875,501
+268,954
+44% +$5.08M 0.01% 1456
2020
Q2 		$13.2M Buy
606,547
+386,101
+175% +$8.84M ﹤0.01% 1482
2020
Q1 		$5.1M Sell
220,446
-28,768
-12% -$836K ﹤0.01% 1870
2019
Q4 		$8.22M Buy
249,214
+30,472
+14% +$977K ﹤0.01% 1884
2019
Q3 		$6.96M Sell
218,742
-35,376
-14% -$1.03M ﹤0.01% 1937
2019
Q2 		$6.53M Sell
254,118
-75,506
-23% -$1.92M ﹤0.01% 2020
2019
Q1 		$8.37M Sell
329,624
-74,280
-18% -$2.22M ﹤0.01% 1685
2018
Q4 		$13.7M Sell
403,904
-109,177
-21% -$3.55M 0.01% 1348
2018
Q3 		$18.3M Buy
513,081
+197,937
+63% +$6.99M 0.01% 1337
2018
Q2 		$10.9M Buy
315,144
+119,520
+61% +$4.19M ﹤0.01% 1614
2018
Q1 		$6.58M Buy
195,624
+90,099
+85% +$2.85M ﹤0.01% 1793
2017
Q4 		$4.03M Buy
105,525
+3,659
+4% +$146K ﹤0.01% 2125
2017
Q3 		$3.82M Sell
101,866
-10
-0% -$353 ﹤0.01% 2137
2017
Q2 		$3.8M Buy
101,876
+8,134
+9% +$294K ﹤0.01% 2121
2017
Q1 		$3.68M Sell
93,742
-34,696
-27% -$1.3M ﹤0.01% 2199
2016
Q4 		$4.47M Buy
128,438
+32,780
+34% +$1.29M ﹤0.01% 2049
2016
Q3 		$3.76M Buy
95,658
+365
+0.4% +$14.6K ﹤0.01% 2158
2016
Q2 		$3.6M Sell
95,293
-71,785
-43% -$2.4M ﹤0.01% 2129
2016
Q1 		$6.42M Sell
167,078
-55,968
-25% -$2.08M ﹤0.01% 1678
2015
Q4 		$10.7M Buy
223,046
+12,123
+6% +$561K ﹤0.01% 1454
2015
Q3 		$8.32M Sell
210,923
-3,369
-2% -$143K ﹤0.01% 1537
2015
Q2 		$9.12M Buy
214,292
+35,929
+20% +$1.43M ﹤0.01% 1593
2015
Q1 		$7.04M Buy
178,363
+18,415
+12% +$679K ﹤0.01% 1730
2014
Q4 		$5.76M Sell
159,948
-3,106
-2% -$104K ﹤0.01% 1812
2014
Q3 		$4.81M Buy
163,054
+46,066
+39% +$1.27M ﹤0.01% 1964
2014
Q2 		$2.94M Buy
116,988
+21,702
+23% +$537K ﹤0.01% 2337
2014
Q1 		$2.46M Sell
95,286
-46,851
-33% -$1.18M ﹤0.01% 2428
2013
Q4 		$3.2M Buy
142,137
+50,955
+56% +$984K ﹤0.01% 2334
2013
Q3 		$1.29M Buy
91,182
+14,160
+18% +$189K ﹤0.01% 2858
2013
Q2 		$1.05M Buy
+77,022
New +$1.05M ﹤0.01% 2833

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Invesco's NTUS Position: Q3 2022 in Review

Invesco sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 202,625 shares — an estimated $6.64M sold.

Invesco first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $18.3M in Q3 2018. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Invesco reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Invesco sold 202,625 Natus Medical Inc shares in Q3 2022, an estimated $6.64M.
  • Invesco first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
  • Invesco's Natus Medical Inc position peaked at $18.3M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Invesco's 13F filing for Q3 2022, filed 14 Nov 2022.